DENDREON CORP (DNDN)
23.48
$0.00 (0.00% )
08:45AM (15 mins delay)
DNDN
$23.48
$0.00 (0.00% )
You need to upgrade your Flash Player
Last:
$23.48
High:
-
Prev Close:
$23.48
Low:
-
Open:
-
Mkt Cap:
$2.52B
Change:
$0.00
(
0.00%
)
52Wk High:
$27.40
Vol:
0
52Wk Low:
$2.55
Avg Volume:
4,876,492
Shares:
N/A
EPS:
-
PE Ratio:
-
Start trading DNDN with real money!
Company Description
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Comments on DNDN
Stanley Mahoe
via Twitter
Jun 29 10:18 PM
$DNDN Nobody's talking bout wamuq. Made $2500 since Jan. Own 71290 shares @.10 per share. Check it out and do the math. HOT!!!!!
Comment
Russell 3,000 Stocks Up More than 200% Year to Date
06/28/2009
Russell Indexing Reshuffle Moves Healthcare Stocks: CXM, CTIC, HEB, CPD
06/26/2009
Cramer's Lightning Round - Mindshare is Going towards Bing (6/22/09)
06/23/2009
A Healthy Dose of Funding for Pharma, Biotech
06/21/2009
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
06/19/2009
GlobalEquityReport.com Issues Market Movers Today: FEED, AIG, DNDN, BAC, GS, JPM
06/15/2009
Best Performing Stocks of the Last Quarter
06/15/2009
Quarterly Changes to the NASDAQ Q-50 Index
06/12/2009
GlobeNewswire
Short Term For The Long Haul
06/12/2009
David Moore
GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN
06/11/2009
Dendreon: Charting the Course to Big Profits
06/10/2009
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
06/05/2009
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
06/02/2009
Biotech Stocks and the ASCO-Effect
06/01/2009
Russell 3000 Stocks Up 200% or More Year to Date
05/29/2009